The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Tranexamic Acid Market Research Report 2024
Synopsis
Tranexamic acid is a white crystalline powder, odorless, slightly bitter in taste, easily soluble in water, almost insoluble in ethanol, acetone, chloroform or ether. Tranexamic acid is a medicine used to treat or prevent excessive blood loss due to major trauma, postpartum hemorrhage, surgery, tooth extraction, nosebleeds, or menorrhagia. It is also used for hereditary angioedema. It can be taken orally or given intravenously.
Global Medical Tranexamic Acid market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Tranexamic Acid market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Tranexamic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Wockhardt Ltd.
FDC Limited
Taicang Pharmaceutical Factory
Asahi Kasei Finechem
Cipla
Taj Pharmaceutical Ltd.
Wuhan Xinzekang Chemical Co., Ltd.
Vega Pharma Limited
Dalian Richon Chem Co., Ltd.
Nanjing Gemsen International Co., Ltd.
Changzhou Hangyu Pharmaceutical Technology Co.,Ltd.
Hunan Dongting Pharmaceuticals
Yinsheng Pharmaceutical
Mascot Industries
Alembic Ltd.
Hangzhou Lianzheng Chemicals Co., Ltd.
Segment by Type
Tablet
Injection
Oral Liquid
Segment by Application
Menstrual and Postoperative Bleeding
Whitening Acne
Hereditary Angioedema
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Tranexamic Acid report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Tranexamic acid is a white crystalline powder, odorless, slightly bitter in taste, easily soluble in water, almost insoluble in ethanol, acetone, chloroform or ether. Tranexamic acid is a medicine used to treat or prevent excessive blood loss due to major trauma, postpartum hemorrhage, surgery, tooth extraction, nosebleeds, or menorrhagia. It is also used for hereditary angioedema. It can be taken orally or given intravenously.
Global Medical Tranexamic Acid market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Tranexamic Acid market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Tranexamic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Wockhardt Ltd.
FDC Limited
Taicang Pharmaceutical Factory
Asahi Kasei Finechem
Cipla
Taj Pharmaceutical Ltd.
Wuhan Xinzekang Chemical Co., Ltd.
Vega Pharma Limited
Dalian Richon Chem Co., Ltd.
Nanjing Gemsen International Co., Ltd.
Changzhou Hangyu Pharmaceutical Technology Co.,Ltd.
Hunan Dongting Pharmaceuticals
Yinsheng Pharmaceutical
Mascot Industries
Alembic Ltd.
Hangzhou Lianzheng Chemicals Co., Ltd.
Segment by Type
Tablet
Injection
Oral Liquid
Segment by Application
Menstrual and Postoperative Bleeding
Whitening Acne
Hereditary Angioedema
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Tranexamic Acid report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Medical Tranexamic Acid Market Overview
1.1 Product Overview and Scope of Medical Tranexamic Acid
1.2 Medical Tranexamic Acid Segment by Type
1.2.1 Global Medical Tranexamic Acid Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Injection
1.2.4 Oral Liquid
1.3 Medical Tranexamic Acid Segment by Application
1.3.1 Global Medical Tranexamic Acid Market Value by Application: (2023-2029)
1.3.2 Menstrual and Postoperative Bleeding
1.3.3 Whitening Acne
1.3.4 Hereditary Angioedema
1.3.5 Others
1.4 Global Medical Tranexamic Acid Market Size Estimates and Forecasts
1.4.1 Global Medical Tranexamic Acid Revenue 2018-2029
1.4.2 Global Medical Tranexamic Acid Sales 2018-2029
1.4.3 Global Medical Tranexamic Acid Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Tranexamic Acid Market Competition by Manufacturers
2.1 Global Medical Tranexamic Acid Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Tranexamic Acid Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Tranexamic Acid Average Price by Manufacturers (2018-2023)
2.4 Global Medical Tranexamic Acid Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Tranexamic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Tranexamic Acid, Product Type & Application
2.7 Medical Tranexamic Acid Market Competitive Situation and Trends
2.7.1 Medical Tranexamic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Tranexamic Acid Players Market Share by Revenue
2.7.3 Global Medical Tranexamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Tranexamic Acid Retrospective Market Scenario by Region
3.1 Global Medical Tranexamic Acid Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Tranexamic Acid Global Medical Tranexamic Acid Sales by Region: 2018-2029
3.2.1 Global Medical Tranexamic Acid Sales by Region: 2018-2023
3.2.2 Global Medical Tranexamic Acid Sales by Region: 2024-2029
3.3 Global Medical Tranexamic Acid Global Medical Tranexamic Acid Revenue by Region: 2018-2029
3.3.1 Global Medical Tranexamic Acid Revenue by Region: 2018-2023
3.3.2 Global Medical Tranexamic Acid Revenue by Region: 2024-2029
3.4 North America Medical Tranexamic Acid Market Facts & Figures by Country
3.4.1 North America Medical Tranexamic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Tranexamic Acid Sales by Country (2018-2029)
3.4.3 North America Medical Tranexamic Acid Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Tranexamic Acid Market Facts & Figures by Country
3.5.1 Europe Medical Tranexamic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Tranexamic Acid Sales by Country (2018-2029)
3.5.3 Europe Medical Tranexamic Acid Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Tranexamic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Tranexamic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Tranexamic Acid Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Tranexamic Acid Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Tranexamic Acid Market Facts & Figures by Country
3.7.1 Latin America Medical Tranexamic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Tranexamic Acid Sales by Country (2018-2029)
3.7.3 Latin America Medical Tranexamic Acid Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Tranexamic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Tranexamic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Tranexamic Acid Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Tranexamic Acid Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Tranexamic Acid Sales by Type (2018-2029)
4.1.1 Global Medical Tranexamic Acid Sales by Type (2018-2023)
4.1.2 Global Medical Tranexamic Acid Sales by Type (2024-2029)
4.1.3 Global Medical Tranexamic Acid Sales Market Share by Type (2018-2029)
4.2 Global Medical Tranexamic Acid Revenue by Type (2018-2029)
4.2.1 Global Medical Tranexamic Acid Revenue by Type (2018-2023)
4.2.2 Global Medical Tranexamic Acid Revenue by Type (2024-2029)
4.2.3 Global Medical Tranexamic Acid Revenue Market Share by Type (2018-2029)
4.3 Global Medical Tranexamic Acid Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Tranexamic Acid Sales by Application (2018-2029)
5.1.1 Global Medical Tranexamic Acid Sales by Application (2018-2023)
5.1.2 Global Medical Tranexamic Acid Sales by Application (2024-2029)
5.1.3 Global Medical Tranexamic Acid Sales Market Share by Application (2018-2029)
5.2 Global Medical Tranexamic Acid Revenue by Application (2018-2029)
5.2.1 Global Medical Tranexamic Acid Revenue by Application (2018-2023)
5.2.2 Global Medical Tranexamic Acid Revenue by Application (2024-2029)
5.2.3 Global Medical Tranexamic Acid Revenue Market Share by Application (2018-2029)
5.3 Global Medical Tranexamic Acid Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Medical Tranexamic Acid Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Wockhardt Ltd.
6.2.1 Wockhardt Ltd. Corporation Information
6.2.2 Wockhardt Ltd. Description and Business Overview
6.2.3 Wockhardt Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Wockhardt Ltd. Medical Tranexamic Acid Product Portfolio
6.2.5 Wockhardt Ltd. Recent Developments/Updates
6.3 FDC Limited
6.3.1 FDC Limited Corporation Information
6.3.2 FDC Limited Description and Business Overview
6.3.3 FDC Limited Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.3.4 FDC Limited Medical Tranexamic Acid Product Portfolio
6.3.5 FDC Limited Recent Developments/Updates
6.4 Taicang Pharmaceutical Factory
6.4.1 Taicang Pharmaceutical Factory Corporation Information
6.4.2 Taicang Pharmaceutical Factory Description and Business Overview
6.4.3 Taicang Pharmaceutical Factory Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Taicang Pharmaceutical Factory Medical Tranexamic Acid Product Portfolio
6.4.5 Taicang Pharmaceutical Factory Recent Developments/Updates
6.5 Asahi Kasei Finechem
6.5.1 Asahi Kasei Finechem Corporation Information
6.5.2 Asahi Kasei Finechem Description and Business Overview
6.5.3 Asahi Kasei Finechem Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Asahi Kasei Finechem Medical Tranexamic Acid Product Portfolio
6.5.5 Asahi Kasei Finechem Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cipla Medical Tranexamic Acid Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Taj Pharmaceutical Ltd.
6.6.1 Taj Pharmaceutical Ltd. Corporation Information
6.6.2 Taj Pharmaceutical Ltd. Description and Business Overview
6.6.3 Taj Pharmaceutical Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Taj Pharmaceutical Ltd. Medical Tranexamic Acid Product Portfolio
6.7.5 Taj Pharmaceutical Ltd. Recent Developments/Updates
6.8 Wuhan Xinzekang Chemical Co., Ltd.
6.8.1 Wuhan Xinzekang Chemical Co., Ltd. Corporation Information
6.8.2 Wuhan Xinzekang Chemical Co., Ltd. Description and Business Overview
6.8.3 Wuhan Xinzekang Chemical Co., Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wuhan Xinzekang Chemical Co., Ltd. Medical Tranexamic Acid Product Portfolio
6.8.5 Wuhan Xinzekang Chemical Co., Ltd. Recent Developments/Updates
6.9 Vega Pharma Limited
6.9.1 Vega Pharma Limited Corporation Information
6.9.2 Vega Pharma Limited Description and Business Overview
6.9.3 Vega Pharma Limited Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Vega Pharma Limited Medical Tranexamic Acid Product Portfolio
6.9.5 Vega Pharma Limited Recent Developments/Updates
6.10 Dalian Richon Chem Co., Ltd.
6.10.1 Dalian Richon Chem Co., Ltd. Corporation Information
6.10.2 Dalian Richon Chem Co., Ltd. Description and Business Overview
6.10.3 Dalian Richon Chem Co., Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Dalian Richon Chem Co., Ltd. Medical Tranexamic Acid Product Portfolio
6.10.5 Dalian Richon Chem Co., Ltd. Recent Developments/Updates
6.11 Nanjing Gemsen International Co., Ltd.
6.11.1 Nanjing Gemsen International Co., Ltd. Corporation Information
6.11.2 Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Description and Business Overview
6.11.3 Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Product Portfolio
6.11.5 Nanjing Gemsen International Co., Ltd. Recent Developments/Updates
6.12 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd.
6.12.1 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Corporation Information
6.12.2 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Description and Business Overview
6.12.3 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Product Portfolio
6.12.5 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Recent Developments/Updates
6.13 Hunan Dongting Pharmaceuticals
6.13.1 Hunan Dongting Pharmaceuticals Corporation Information
6.13.2 Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Description and Business Overview
6.13.3 Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Product Portfolio
6.13.5 Hunan Dongting Pharmaceuticals Recent Developments/Updates
6.14 Yinsheng Pharmaceutical
6.14.1 Yinsheng Pharmaceutical Corporation Information
6.14.2 Yinsheng Pharmaceutical Medical Tranexamic Acid Description and Business Overview
6.14.3 Yinsheng Pharmaceutical Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Yinsheng Pharmaceutical Medical Tranexamic Acid Product Portfolio
6.14.5 Yinsheng Pharmaceutical Recent Developments/Updates
6.15 Mascot Industries
6.15.1 Mascot Industries Corporation Information
6.15.2 Mascot Industries Medical Tranexamic Acid Description and Business Overview
6.15.3 Mascot Industries Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Mascot Industries Medical Tranexamic Acid Product Portfolio
6.15.5 Mascot Industries Recent Developments/Updates
6.16 Alembic Ltd.
6.16.1 Alembic Ltd. Corporation Information
6.16.2 Alembic Ltd. Medical Tranexamic Acid Description and Business Overview
6.16.3 Alembic Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alembic Ltd. Medical Tranexamic Acid Product Portfolio
6.16.5 Alembic Ltd. Recent Developments/Updates
6.17 Hangzhou Lianzheng Chemicals Co., Ltd.
6.17.1 Hangzhou Lianzheng Chemicals Co., Ltd. Corporation Information
6.17.2 Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Description and Business Overview
6.17.3 Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Product Portfolio
6.17.5 Hangzhou Lianzheng Chemicals Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Tranexamic Acid Industry Chain Analysis
7.2 Medical Tranexamic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Tranexamic Acid Production Mode & Process
7.4 Medical Tranexamic Acid Sales and Marketing
7.4.1 Medical Tranexamic Acid Sales Channels
7.4.2 Medical Tranexamic Acid Distributors
7.5 Medical Tranexamic Acid Customers
8 Medical Tranexamic Acid Market Dynamics
8.1 Medical Tranexamic Acid Industry Trends
8.2 Medical Tranexamic Acid Market Drivers
8.3 Medical Tranexamic Acid Market Challenges
8.4 Medical Tranexamic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
